http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg#Head
http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg#assertion
http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg#provenance
http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg#pubinfo
http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg#assertion
http://purl.obolibrary.org/obo/DOID_9970
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_9970
http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB00191
http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg#association
http://www.w3.org/2000/01/rdf-schema#label
phentermine hydrochloride orally disintegrating tablets are sympathomimetic amine anorectic indicated as a short term adjunct a few weeks in a regimen of weight reduction based on exercise behavioral modification and caloric restriction in the management of exogenous obesity for patients with an initial body mass index greater than or equal to 3 kg m 2 2 1 the limited usefulness of agents of this class including phentermine hydrochloride should be measured against possible risk factors inherent in their use 1 phentermine hydrochloride orally disintegrating tablets are indicated as a short term a few weeks adjunct in a regimen of weight reduction based on exercise behavioral modification and caloric restriction in the management of exogenous obesity for patients with an initial body mass index greater than or equal to 3 kg m 2 2 below is a chart of body mass index bmi based on various heights and weights bmi is calculated by taking the patient s weight in kilograms kg divided by the patient s height in meters m squared metric conversions are as follows pounds 2 2 kg inches x 254 meters body mass index bmi kg m 2 header weight 5 5 3 5 6 5 9 6 6 3 14 27 25 23 21 19 18 15 29 27 24 22 2 19 16 31 28 26 24 22 2 17 33 3 28 25 23 21 18 35 32 29 27 25 23 19 37 34 31 28 26 24 2 39 36 32 3 27 25 21 41 37 34 31 29 26 22 43 39 36 33 3 28 23 45 41 37 34 31 29 24 47 43 39 36 33 3 25 49 44 4 37 34 31 the limited usefulness of agents of this class including phentermine hydrochloride see clinical pharmacology 12 1 12 2
http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg#association
https://w3id.org/biolink/vocab/relation
https://schema.org/TreatmentIndication
https://identifiers.org/drugbank:DB00191
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg#provenance
http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg#pubinfo
http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg#sig
http://purl.org/nanopub/x/hasSignature
Z5156CrHSToPkzrjZE9s6SPVigBAAVoqFvgrjYoyFSrHmO2ERENmLherx51WE6yZ64YovWtmZqAm4M7CSZO84/x3zthXvmZVBpU35sCyYWfwLl5InMB1E+iLvoqRRe9il4SKIVmag++A5LjVR0qVwziDHgZnLvKSWq2Hyx/1Zog=
http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg
http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg
http://purl.org/dc/terms/created
2021-06-27T20:27:35.302+02:00
http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs